Leishmaniasis Treatment Market Report

China Leishmaniasis Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Aug 17, 2023
  • PAGES：144
  • REPORT CODE：GMM1739689
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Leishmaniasis Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merck

    • AEterna Zentaris

    • Pieris Pharmaceuticals

    • Dafra Pharma

    • AEterna Zentaris AG

    • Eurofins Advinus

    By Type:

    • Amphotericin B

    • Pentamidine

    • Meglumine Antimoniate

    • Hydroxyl Amidine Stilbene

    By Application:

    • Visceral Leishmaniasis

    • Cutaneous Leishmaniasis

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Leishmaniasis Treatment Market Overview 2018-2029

    • 1.1 China Leishmaniasis Treatment Industry Development Overview

    • 1.2 China Leishmaniasis Treatment Industry Development History

    • 1.3 China Leishmaniasis Treatment Industry Market Size (2018-2029)

    • 1.4 China Leishmaniasis Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Leishmaniasis Treatment Production Volume, Production Value and Growth Rate of Amphotericin B (2018-2029)

      • 1.4.2 China Leishmaniasis Treatment Production Volume, Production Value and Growth Rate of Pentamidine (2018-2029)

      • 1.4.3 China Leishmaniasis Treatment Production Volume, Production Value and Growth Rate of Meglumine Antimoniate (2018-2029)

      • 1.4.4 China Leishmaniasis Treatment Production Volume, Production Value and Growth Rate of Hydroxyl Amidine Stilbene (2018-2029)

    • 1.5 China Leishmaniasis Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Leishmaniasis Treatment Sales Volume, Sales Value and Growth Rate of Visceral Leishmaniasis (2018-2029)

      • 1.5.2 China Leishmaniasis Treatment Sales Volume, Sales Value and Growth Rate of Cutaneous Leishmaniasis (2018-2029)

    • 1.6 China Leishmaniasis Treatment Market Analysis by Region

      • 1.6.1 North China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Leishmaniasis Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Leishmaniasis Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Leishmaniasis Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Leishmaniasis Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Leishmaniasis Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Leishmaniasis Treatment Industry Development

    Chapter 3 Leishmaniasis TreatmentIndustry Chain Analysis

    • 3.1 Leishmaniasis Treatment Industry Chain

    • 3.2 Leishmaniasis Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Leishmaniasis Treatment Market

    • 3.3 Leishmaniasis Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Leishmaniasis Treatment Market

    Chapter 4 China Leishmaniasis Treatment Market, by Type

    • 4.1 China Leishmaniasis Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Leishmaniasis Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Leishmaniasis Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Leishmaniasis Treatment Production Volume and Growth Rate of Amphotericin B

      • 4.5.2 China Leishmaniasis Treatment Production Volume and Growth Rate of Pentamidine

      • 4.5.3 China Leishmaniasis Treatment Production Volume and Growth Rate of Meglumine Antimoniate

      • 4.5.4 China Leishmaniasis Treatment Production Volume and Growth Rate of Hydroxyl Amidine Stilbene

    Chapter 5 China Leishmaniasis Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Leishmaniasis Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Leishmaniasis Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Leishmaniasis Treatment Market Size and Growth Rate of Visceral Leishmaniasis

      • 5.5.2 China Leishmaniasis Treatment Market Size and Growth Rate of Cutaneous Leishmaniasis

    Chapter 6 China Leishmaniasis Treatment Market, by Region

    • 6.1 China Leishmaniasis Treatment Production Volume and Production Value, by Region

    • 6.2 China Leishmaniasis Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Leishmaniasis Treatment Market Analysis

    • 7.1 North China Leishmaniasis Treatment Market, by Type

    • 7.2 North China Leishmaniasis Treatment Market, by Application

    Chapter 8 Central China Leishmaniasis Treatment Market Analysis

    • 8.1 Central China Leishmaniasis Treatment Market, by Type

    • 8.2 Central China Leishmaniasis Treatment Market, by Application

    Chapter 9 South China Leishmaniasis Treatment Market Analysis

    • 9.1 South China Leishmaniasis Treatment Market, by Type

    • 9.2 South China Leishmaniasis Treatment Market, by Application

    Chapter 10 East China Leishmaniasis Treatment Market Analysis

    • 10.1 East China Leishmaniasis Treatment Market, by Type

    • 10.2 East China Leishmaniasis Treatment Market, by Application

    Chapter 11 Northeast China Leishmaniasis Treatment Market Analysis

    • 11.1 Northeast China Leishmaniasis Treatment Market, by Type

    • 11.2 Northeast China Leishmaniasis Treatment Market, by Application

    Chapter 12 Southwest China Leishmaniasis Treatment Market Analysis

    • 12.1 Southwest China Leishmaniasis Treatment Market, by Type

    • 12.2 Southwest China Leishmaniasis Treatment Market, by Application

    Chapter 13 Northwest China Leishmaniasis Treatment Market Analysis

    • 13.1 Northwest China Leishmaniasis Treatment Market, by Type

    • 13.2 Northwest China Leishmaniasis Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merck

        • 14.1.1 Merck Company Profile

        • 14.1.2 Merck Leishmaniasis Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 AEterna Zentaris

        • 14.2.1 AEterna Zentaris Company Profile

        • 14.2.2 AEterna Zentaris Leishmaniasis Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pieris Pharmaceuticals

        • 14.3.1 Pieris Pharmaceuticals Company Profile

        • 14.3.2 Pieris Pharmaceuticals Leishmaniasis Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Dafra Pharma

        • 14.4.1 Dafra Pharma Company Profile

        • 14.4.2 Dafra Pharma Leishmaniasis Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 AEterna Zentaris AG

        • 14.5.1 AEterna Zentaris AG Company Profile

        • 14.5.2 AEterna Zentaris AG Leishmaniasis Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Eurofins Advinus

        • 14.6.1 Eurofins Advinus Company Profile

        • 14.6.2 Eurofins Advinus Leishmaniasis Treatment Market Performance

        • 14.6.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Leishmaniasis Treatment Industry Research Conclusions

    • 15.2 Leishmaniasis Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Leishmaniasis Treatment Industry Market Size (2018-2029)

    • Figure China Leishmaniasis Treatment Production Volume, Production Value and Growth Rate of Amphotericin B (2018-2029)

    • Figure China Leishmaniasis Treatment Production Volume, Production Value and Growth Rate of Pentamidine (2018-2029)

    • Figure China Leishmaniasis Treatment Production Volume, Production Value and Growth Rate of Meglumine Antimoniate (2018-2029)

    • Figure China Leishmaniasis Treatment Production Volume, Production Value and Growth Rate of Hydroxyl Amidine Stilbene (2018-2029)

    • Figure China Leishmaniasis Treatment Sales Volume, Sales Value and Growth Rate of Visceral Leishmaniasis (2018-2029)

    • Figure China Leishmaniasis Treatment Sales Volume, Sales Value and Growth Rate of Cutaneous Leishmaniasis (2018-2029)

    • Figure North China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Leishmaniasis Treatment Market Size and Growth Rate from 2018-2029

    • Figure Leishmaniasis Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Leishmaniasis Treatment Market Share by Type in 2018

    • Figure China Leishmaniasis Treatment Market Share by Type in 2023

    • Figure China Leishmaniasis Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Leishmaniasis Treatment Production Volume and Growth Rate of Amphotericin B (2018-2023)

    • Figure China Leishmaniasis Treatment Production Volume and Growth Rate of Pentamidine (2018-2023)

    • Figure China Leishmaniasis Treatment Production Volume and Growth Rate of Meglumine Antimoniate (2018-2023)

    • Figure China Leishmaniasis Treatment Production Volume and Growth Rate of Hydroxyl Amidine Stilbene (2018-2023)

    • Figure China Leishmaniasis Treatment Market Share by Application in 2018

    • Figure China Leishmaniasis Treatment Market Share by Application in 2023

    • Figure China Leishmaniasis Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Leishmaniasis Treatment Market Size and Growth Rate of Visceral Leishmaniasis (2018-2023)

    • Figure China Leishmaniasis Treatment Market Size and Growth Rate of Cutaneous Leishmaniasis (2018-2023)

    • Table China Leishmaniasis Treatment Production Volume by Region (2018-2023)

    • Table China Leishmaniasis Treatment Production Volume Share by Region (2018-2023)

    • Figure China Leishmaniasis Treatment Production Volume Share by Region (2018-2023)

    • Table China Leishmaniasis Treatment Production Value by Region (2018-2023)

    • Table China Leishmaniasis Treatment Production Value Share by Region (2018-2023)

    • Figure China Leishmaniasis Treatment Production Value Share by Region (2018-2023)

    • Table China Leishmaniasis Treatment Sales Volume by Region (2018-2023)

    • Table China Leishmaniasis Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Leishmaniasis Treatment Sales Volume Share by Region (2018-2023)

    • Table China Leishmaniasis Treatment Sales Value by Region (2018-2023)

    • Table China Leishmaniasis Treatment Sales Value Share by Region (2018-2023)

    • Figure China Leishmaniasis Treatment Sales Value Share by Region (2018-2023)

    • Table North China Leishmaniasis Treatment Production Volume by Type (2018-2023)

    • Table North China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Table North China Leishmaniasis Treatment Sales Volume by Application (2018-2023)

    • Table North China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Leishmaniasis Treatment Production Volume by Type (2018-2023)

    • Table Central China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Leishmaniasis Treatment Sales Volume by Application (2018-2023)

    • Table Central China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Leishmaniasis Treatment Production Volume by Type (2018-2023)

    • Table South China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Table South China Leishmaniasis Treatment Sales Volume by Application (2018-2023)

    • Table South China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Leishmaniasis Treatment Production Volume by Type (2018-2023)

    • Table East China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Table East China Leishmaniasis Treatment Sales Volume by Application (2018-2023)

    • Table East China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Leishmaniasis Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Leishmaniasis Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Leishmaniasis Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Leishmaniasis Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Leishmaniasis Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Leishmaniasis Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Leishmaniasis Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Leishmaniasis Treatment Sales Volume Share by Application (2018-2023)

    • Table Merck Company Profile

    • Table Merck Leishmaniasis Treatment Revenue, Price and Gross (2018-2023)

    • Table AEterna Zentaris Company Profile

    • Table AEterna Zentaris Leishmaniasis Treatment Revenue, Price and Gross (2018-2023)

    • Table Pieris Pharmaceuticals Company Profile

    • Table Pieris Pharmaceuticals Leishmaniasis Treatment Revenue, Price and Gross (2018-2023)

    • Table Dafra Pharma Company Profile

    • Table Dafra Pharma Leishmaniasis Treatment Revenue, Price and Gross (2018-2023)

    • Table AEterna Zentaris AG Company Profile

    • Table AEterna Zentaris AG Leishmaniasis Treatment Revenue, Price and Gross (2018-2023)

    • Table Eurofins Advinus Company Profile

    • Table Eurofins Advinus Leishmaniasis Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US